ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.

Allergy Asthma & Immunology Research, published by the Korean Academy of Asthma Allergy & Clinical Immunology, is a leading journal dedicated to advancing the fields of immunology, allergy, and respiratory medicine. With an ISSN of 2092-7355 and an E-ISSN of 2092-7363, this esteemed publication has been a cornerstone for researchers and practitioners since its inception in 2009 and continues to disseminate critical findings through till 2024. The journal is ranked in the Q3 category in Immunology and the Q2 category in Immunology and Allergy as well as Pulmonary and Respiratory Medicine, illustrating its impact in these vital fields. With a solid Scopus ranking in multiple sub-disciplines, the journal not only contributes to the scientific discourse but also promotes innovative research and clinical practices. Although currently operating without an open access model, the journal remains highly regarded for its thorough peer-review process and commitment to academic excellence, making it an essential resource for professionals, researchers, and students passionate about advancing knowledge in allergy, asthma, and immunology.

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.

The Journal of Allergy and Clinical Immunology-In Practice, published by ELSEVIER, stands as a leading platform in the field of allergy and immunology, specifically tailored for practitioners and researchers. With an impressive 2023 Q1 ranking in both the Immunology and Allergy categories, this journal demonstrates a significant impact within the academic community, evidenced by its Scopus rank #41 out of 233 and an impressive percentile rank of 82. The journal focuses on providing advanced studies, clinical findings, and innovative treatment methodologies that address current challenges in allergy and immunology, making it a vital resource for professionals in these fields. With a comprehensive coverage of relevant topics from 2013 to 2024, the journal continues to evolve alongside emerging trends and developments in clinical practice, fostering an environment conducive to scholarly research and application. Although it currently does not offer open access, authors and readers can access a wealth of information and contribute to ongoing dialogues through its robust publication platform.

ALLERGOLOGIE is a prominent academic journal dedicated to the field of immunology and allergy, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany. Since its inception in 1978, the journal has provided a vital platform for researchers, clinicians, and students to disseminate their findings, share insights, and foster advancements in the understanding of allergic diseases and immunological responses. With an ISSN of 0344-5062 and an E-ISSN of the same number, it is a respected source within its category, currently ranked in the 2023 Q4 of the Scopus metrics in immunology and allergy, reflecting its commitment to quality and scholarly rigor. Although not fully open access, ALLERGOLOGIE makes significant contributions to the dialogue on allergy-related topics, encouraging engagement from its readership through a diverse array of articles that span from clinical trials to innovative research methods. This journal continues to be an essential resource for anyone involved in the pursuit of knowledge in allergy and immunology.